英诺特1月26日获融资买入1661.74万元，融资余额2.46亿元

Group 1 - The core viewpoint of the news is that Innotech has shown significant trading activity and financial performance indicators, with a focus on its stock performance and financing status [1][2][3] - On January 26, Innotech's stock price increased by 0.22%, with a trading volume of 130 million yuan. The financing buy-in amount was 16.62 million yuan, while the financing repayment was 13.11 million yuan, resulting in a net financing buy of 3.51 million yuan [1] - As of January 26, the total balance of margin trading for Innotech was 246 million yuan, which accounts for 9.94% of its market capitalization, indicating a high level compared to the past year [1] - In terms of securities lending, on January 26, Innotech repaid 1,200 shares and sold 1,000 shares, with a selling amount of 35,600 yuan. The remaining securities lending volume was 8,100 shares, with a balance of 288,700 yuan, also indicating a high level compared to the past year [1] Group 2 - As of September 30, Innotech had 8,037 shareholders, an increase of 10.57% from the previous period, while the average circulating shares per person decreased by 8.86% to 8,627 shares [2] - For the period from January to September 2025, Innotech reported an operating income of 330 million yuan, a year-on-year decrease of 36.56%, and a net profit attributable to shareholders of 131 million yuan, down 46.37% year-on-year [2] - Since its A-share listing, Innotech has distributed a total of 152 million yuan in dividends. As of September 30, 2025, the medical device ETF (159883) was the ninth largest circulating shareholder, holding 498,000 shares as a new shareholder [3]